NCT06263972

Brief Summary

The goal of this study is to demonstrate the effectiveness of treating fibromyalgia using combination of electrical stimulation with aerobic activity. Participants will be randomly assigned to stimulation in a ratio of 1:1:1. 120 participants (40 in each group). The therapeutic course will include moderate aerobic physical activity (at 60% of the target heart rate adjusted for age) 3 times a week for 4 weeks (a week of adjustment, and 3 weeks of treatment), along with low current electrical stimulation for 3 weeks.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Mar 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Mar 2024Jul 2026

First Submitted

Initial submission to the registry

December 11, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 16, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

February 16, 2024

Status Verified

February 1, 2024

Enrollment Period

2 years

First QC Date

December 11, 2023

Last Update Submit

February 14, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Study objectives: • Comparing the effectiveness of direct electric current stimulation between the two stimulus areas Numeric pain rating scale.

    Study objectives: • Comparing the effectiveness of direct electric current stimulation (tDCS) between the two stimulus areas and in relation to blood stimulation. Based on: Numeric pain rating scale (score range from 1 to 10)

    3 months

  • Study objectives: • Comparing the effectiveness of direct electric current stimulation (tDCS) between the two stimulus areas and in relation Adult sensory profile test Raw score.

    Study objectives: • Comparing the effectiveness of direct electric current stimulation (tDCS) between the two stimulus areas and in relation to blood stimulation. Based on: Adult sensory profile test Raw score

    3 months

  • Study objectives: • Comparing the effectiveness of direct electric current stimulation between the two stimulus areas and in relation to The Montreal Cognitive Assessment (MoCA) score.

    Study objectives: • Comparing the effectiveness of direct electric current stimulation (tDCS) between the two stimulus areas and in relation to The Montreal Cognitive Assessment (MoCA) score. Based on: The Montreal Cognitive Assessment (MoCA) score

    3 months

  • Study objectives: • Comparing the effectiveness of direct electric current stimulation between the two stimulus areas and in relation to Generalized Anxiety Disorder 7-Item Scale

    Study objectives: • Comparing the effectiveness of direct electric current stimulation (tDCS) between the two stimulus areas and in relation to blood stimulation. Based on: The Generalized Anxiety Disorder 7-Item Scale

    3 months

Study Arms (3)

Direct Stimulation of the Primary Motor Cortex (M1) Combined With Aerobic Activity.

ACTIVE COMPARATOR

low current electrical stimulation to Motor cortex for 3 weeks.

Device: Direct Stimulation to Motor CortexBehavioral: erobic physical activity

Direct Stimulation the Prefrontal Cortex Combined With Aerobic Activity

ACTIVE COMPARATOR

with low current electrical stimulation to Prefrontal cortex for 3 weeks.

Device: Direct Stimulation Prefrontal CortexBehavioral: erobic physical activity

Shame Stimulation Combined With Aerobic Activity

SHAM COMPARATOR

Shame low current electrical stimulation to cortex for 3 weeks.

Device: Shame cortex stimulationBehavioral: erobic physical activity

Interventions

The therapeutic course will include moderate aerobic physical activity (at 60% of the target heart rate adjusted for age) 3 times a week for 4 weeks (a week of adjustment, and 3 weeks of treatment), along with low current electrical stimulation to prefrontal cortex for 3 weeks.

Direct Stimulation the Prefrontal Cortex Combined With Aerobic Activity

The therapeutic course will include moderate aerobic physical activity (at 60% of the target heart rate adjusted for age) 3 times a week for 4 weeks (a week of adjustment, and 3 weeks of treatment), along with shame low current electrical stimulation to cortex for 3 weeks.

Shame Stimulation Combined With Aerobic Activity

The therapeutic course will include moderate aerobic physical activity (at 60% of the target heart rate adjusted for age) 3 times a week for 4 weeks (a week of adjustment, and 3 weeks of treatment), along with low current electrical stimulation to Motor cortex for 3 weeks.

Direct Stimulation of the Primary Motor Cortex (M1) Combined With Aerobic Activity.

Aerobic physical activity (at 60% of the target heart rate adjusted for age) 3 times a week for 4 weeks (a week of adjustment, and 3 weeks of treatment),

Direct Stimulation of the Primary Motor Cortex (M1) Combined With Aerobic Activity.Direct Stimulation the Prefrontal Cortex Combined With Aerobic ActivityShame Stimulation Combined With Aerobic Activity

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed Fibromyalgia
  • Pain scale level of 4 or higher
  • Fail to achieve adequate pain relief with Fibromyalgia treatments
  • stable Fibromyalgia treatment for at least 4 weeks.
  • Ability to perform aerobic exercise

You may not qualify if:

  • Other Causes of pain
  • Psychotic disorder
  • Severe Depression
  • Cognitive disorder
  • Drug or alcohol abuse in the last 6 months
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor, Head of neuromodulation

Study Record Dates

First Submitted

December 11, 2023

First Posted

February 16, 2024

Study Start

March 1, 2024

Primary Completion

March 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

February 16, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share